Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Journal of Visualized Experiments : Jove|February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord bloodM Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.
Cancer Gene Therapy|May 15, 2018
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of gliomaJohn A Barrett, Hongliang Cai, John Miao, et al.
Human Gene Therapy|April 12, 2018
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic LeukemiaChiara F Magnani, Claudia Mezzanotte, Claudia Cappuzzello, et al.
Cancer Research|May 3, 2011
Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010Hildegund C J Ertl, John Zaia, Steven A Rosenberg, et al.
Gene Therapy|April 1, 2011
The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptorZ Jin, S Maiti, H Huls, et al.
Oncoimmunology|April 9, 2016
The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacityMarie-Andrée Forget, Cara Haymaker, Jennifer B Dennison, et al.
Scientific Reports|March 29, 2014
Tumor lysing genetically engineered T cells loaded with multi-modal imaging agentsParijat Bhatnagar, Mian Alauddin, James A Bankson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2013
Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptorDrew C Deniger, Kirsten Switzer, Tiejuan Mi, et al.
Cancer Research|November 17, 2006
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cellsClaudia M Kowolik, Max S Topp, Sergio Gonzalez, et al.
Plos One|August 23, 2016
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ TumorsRadhika Thokala, Simon Olivares, Tiejuan Mi, et al.
Pageof 14